dc.contributor.author |
Mahfouz R.A. |
dc.contributor.author |
Cortas N.K. |
dc.contributor.author |
Charafeddine K.M. |
dc.contributor.author |
Abdul Khalik R.N. |
dc.contributor.author |
Sarieddine D.S. |
dc.contributor.author |
Kadi R.H. |
dc.contributor.author |
Daher R.T. |
dc.contributor.editor |
|
dc.date |
Aug-2012 |
dc.date.accessioned |
2017-10-05T15:59:34Z |
dc.date.available |
2017-10-05T15:59:34Z |
dc.date.issued |
2012 |
dc.identifier |
10.1016/j.gene.2012.05.029 |
dc.identifier.isbn |
|
dc.identifier.issn |
03781119 |
dc.identifier.uri |
http://hdl.handle.net/10938/19084 |
dc.description.abstract |
Hyperhomocysteinemia is associated with several vascular and teratogenic conditions. Determinants of total homocysteine concentrations include genetic and nutritional factors. This study assesses the relation between homocysteine concentrations and MTHFR gene polymorphisms at two common alleles (C677T (rs1801133) and A1298C (rs1801131)) as well as other predictors of homocysteine (folate, vitamin B 12, body mass index (BMI), age, and gender) in a group of healthy Lebanese: 109 males and 124 females aged 17-55years. We used serum for the determination of homocysteine, folate and vitamin B 12 levels and blood drawn in EDTA tubes for molecular analysis of MTHFR polymorphisms. Hyperhomocysteinemia was present in 59-233 (25.3percent) of the subjects, with male-female ratio of 1.95. Multivariable regression analysis showed that homocysteine levels were negatively related to folate and vitamin B 12 and positively related to male gender and C677T homozygosity; but not A1298C polymorphism, BMI or age. The prevalence of wild, heterozygous, and homozygous C677T genotypes was 45.0percent, 43.3percent and 11.6percent, respectively; with a carrier frequency of 54.9percent and allelic frequency of 33.3percent. The A1298C genotypic prevalence was 39.5percent, 30.9percent, and 29.6percent respectively; with a carrier frequency of 60.5percent and allelic frequency of 45.1percent. C677T-A1289C compound heterozygosity was present in 47-233 (20.2percent) of volunteers. In this first pilot study, gender, folate, vitamin B 12 and C677T mutational status could explain around 32percent of homocysteine variations. Future larger studies are recommended to investigate other predictors of homocysteine variation and combine them with markers explored in this and other studies, in order to evaluate their impact on vascular and-or congenital diseases. © 2012 Elsevier B.V. |
dc.format.extent |
|
dc.format.extent |
Pages: (175-180) |
dc.language |
English |
dc.publisher |
AMSTERDAM |
dc.relation.ispartof |
Publication Name: Gene; Publication Year: 2012; Volume: 504; no. 2; Pages: (175-180); |
dc.relation.ispartofseries |
|
dc.relation.uri |
|
dc.source |
Scopus |
dc.subject.other |
|
dc.title |
Correlation of methylenetetrahydrofolate reductase polymorphisms with homocysteine metabolism in healthy Lebanese adults |
dc.type |
Article |
dc.contributor.affiliation |
Mahfouz, R.A., Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon |
dc.contributor.affiliation |
Cortas, N.K., Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon |
dc.contributor.affiliation |
Charafeddine, K.M., Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon |
dc.contributor.affiliation |
Abdul Khalik, R.N., Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon |
dc.contributor.affiliation |
Sarieddine, D.S., Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon |
dc.contributor.affiliation |
Kadi, R.H., Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon |
dc.contributor.affiliation |
Daher, R.T., Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon |
dc.contributor.authorAddress |
Daher, R.T.; Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, P.O. Box: 11-0236, Beirut 1107-2020, Lebanon; email: rd02@aub.edu.lb |
dc.contributor.authorCorporate |
University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Pathology and Laboratory Medicine; |
dc.contributor.authorDepartment |
Pathology and Laboratory Medicine |
dc.contributor.authorDivision |
|
dc.contributor.authorEmail |
rd02@aub.edu.lb |
dc.contributor.authorFaculty |
Faculty of Medicine |
dc.contributor.authorInitials |
Mahfouz, RA |
dc.contributor.authorInitials |
Cortas, NK |
dc.contributor.authorInitials |
Charafeddine, KM |
dc.contributor.authorInitials |
Khalik, RNA |
dc.contributor.authorInitials |
Sarieddine, DS |
dc.contributor.authorInitials |
Kadi, RH |
dc.contributor.authorInitials |
Daher, RT |
dc.contributor.authorOrcidID |
|
dc.contributor.authorReprintAddress |
Daher, RT (reprint author), Amer Univ Beirut, Med Ctr, Dept Pathol and Lab Med, POB 11-0236, Beirut 11072020, Lebanon. |
dc.contributor.authorResearcherID |
|
dc.contributor.authorUniversity |
American University of Beirut Medical Center |
dc.description.cited |
Abbate R, 1998, THROMB HAEMOSTASIS, V79, P727; Al-Habboubi HH, 2004, THROMB HAEMOSTASIS, V91, P843; Almawi WY, 2004, AM J HEMATOL, V76, P85, DOI 10.1002-ajh.20047; [Anonymous], 2002, JAMA, V288, P2015; Armitage JM, 2010, JAMA-J AM MED ASSOC, V303, P2486, DOI 10.1001-jama.2010.840; ARNESEN E, 1995, INT J EPIDEMIOL, V24, P704, DOI 10.1093-ije-24.4.704; Bailey LB, 2002, J NUTR, V132, P1872; Bakker RC, 1997, PHARM WORLD SCI, V19, P126, DOI 10.1023-A:1008634632501; Blom HJ, 2011, J INHERIT METAB DIS, V34, P75, DOI 10.1007-s10545-010-9177-4; Boduroglu K, 1998, ARCH DIS CHILD, V78, pF235; Botto LD, 2000, AM J EPIDEMIOL, V151, P862; Bowen DJ, 1998, THROMB HAEMOSTASIS, V79, P949; Brugada R, 1997, ATHEROSCLEROSIS, V128, P107, DOI 10.1016-S0021-9150(96)05977-1; Clarke R, 2011, CLIN CHEM, V57, P1201, DOI 10.1373-clinchem.2011.164855; Graham IM, 1997, JAMA-J AM MED ASSOC, V277, P1775, DOI 10.1001-jama.277.22.1775; Huh HJ, 2006, THROMB RES, V117, P501, DOI 10.1016-j.thromres.2005.04.009; Jacques PF, 1996, CIRCULATION, V93, P7; Koch MC, 1998, EUR J PEDIATR, V157, P487, DOI 10.1007-s004310050860; McAndrew PE, 1996, THROMB RES, V83, P195, DOI 10.1016-0049-3848(96)00121-1; Nikitin Iu P., 2006, KARDIOLOGIYA, V46, P30; Nygard O, 1997, NEW ENGL J MED, V337, P230, DOI 10.1056-NEJM199707243370403; Papandreou D, 2006, CLIN NUTR, V25, P797, DOI 10.1016-j.clnu.2006.02.006; Qu QG, 2010, PUBLIC HEALTH NUTR, V13, P1974, DOI 10.1017-S1368980010000546; ROBINSON K, 1995, CIRCULATION, V92, P2825; Sabbagh AS, 2008, GENET TEST, V12, P75, DOI 10.1089-gte.2007.0064; Sadewa Ahmad Hamim, 2002, Kobe Journal of Medical Sciences, V48, P137; Safarinejad MR, 2010, ARCH MED RES, V41, P410, DOI 10.1016-j.arcmed.2010.08.005; Salden A, 1997, BRIT J HAEMATOL, V99, P472; Schneider JA, 1998, AM J HUM GENET, V62, P1258, DOI 10.1086-301836; SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001-jama.270.22.2693; Shaw GM, 1998, AM J EPIDEMIOL, V148, P30; Szucs TD, 2005, CARDIOVASC DRUG THER, V19, P365, DOI 10.1007-s10557-005-3682-y; Taher A, 2001, THROMB HAEMOSTASIS, V86, P723; Tanaka T, 2009, AM J HUM GENET, V84, P477, DOI 10.1016-j.ajhg.2009.02.011; Taskin G, 2006, ACTA CARDIOL, V61, P35, DOI 10.2143-AC.61.1.2005138; Tavares EF, 2004, ETHNIC DIS, V14, P49; Trembath D, 1999, TERATOLOGY, V59, P331, DOI 10.1002-(SICI)1096-9926(199905)59:5331::AID-TERA43.0.CO;2-L; Ueland PM, 2007, CLIN CHEM, V53, P807, DOI 10.1373-clinchem.2007.085480; van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086-301825; Weisberg I, 1998, MOL GENET METAB, V64, P169, DOI 10.1006-mgme.1998.2714; Weisberg IS, 2001, ATHEROSCLEROSIS, V156, P409, DOI 10.1016-S0021-9150(00)00671-7; Yaman H, 2009, ACTA CARDIOL, V64, P247, DOI 10.2143-AC.64.2.2036145 |
dc.description.citedCount |
2 |
dc.description.citedTotWOSCount |
3 |
dc.description.citedWOSCount |
3 |
dc.format.extentCount |
6 |
dc.identifier.articleNo |
|
dc.identifier.coden |
GENED |
dc.identifier.pubmedID |
22652272 |
dc.identifier.scopusID |
84862770191 |
dc.identifier.url |
|
dc.publisher.address |
PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS |
dc.relation.ispartofConference |
|
dc.relation.ispartofConferenceCode |
|
dc.relation.ispartofConferenceDate |
|
dc.relation.ispartofConferenceHosting |
|
dc.relation.ispartofConferenceLoc |
|
dc.relation.ispartofConferenceSponsor |
|
dc.relation.ispartofConferenceTitle |
|
dc.relation.ispartofFundingAgency |
|
dc.relation.ispartOfISOAbbr |
Gene |
dc.relation.ispartOfIssue |
2 |
dc.relation.ispartOfPart |
|
dc.relation.ispartofPubTitle |
Gene |
dc.relation.ispartofPubTitleAbbr |
Gene |
dc.relation.ispartOfSpecialIssue |
|
dc.relation.ispartOfSuppl |
|
dc.relation.ispartOfVolume |
504 |
dc.source.ID |
WOS:000306775100005 |
dc.type.publication |
Journal |
dc.subject.otherAuthKeyword |
A1298C |
dc.subject.otherAuthKeyword |
C677T |
dc.subject.otherAuthKeyword |
Folate |
dc.subject.otherAuthKeyword |
Homocysteine |
dc.subject.otherAuthKeyword |
Vitamin B 12 |
dc.subject.otherChemCAS |
5,10 methylenetetrahydrofolate reductase (FADH2), 9028-69-7 |
dc.subject.otherChemCAS |
cyanocobalamin, 53570-76-6, 68-19-9, 8064-09-3 |
dc.subject.otherChemCAS |
folic acid, 59-30-3, 6484-89-5 |
dc.subject.otherChemCAS |
homocysteine, 454-28-4, 6027-13-0 |
dc.subject.otherChemCAS |
DNA Primers |
dc.subject.otherChemCAS |
Homocysteine, 454-28-4 |
dc.subject.otherChemCAS |
Methylenetetrahydrofolate Reductase (NADPH2), 1.5.1.20 |
dc.subject.otherIndex |
5,10 methylenetetrahydrofolate reductase (FADH2) |
dc.subject.otherIndex |
cyanocobalamin |
dc.subject.otherIndex |
folic acid |
dc.subject.otherIndex |
homocysteine |
dc.subject.otherIndex |
adolescent |
dc.subject.otherIndex |
adult |
dc.subject.otherIndex |
age |
dc.subject.otherIndex |
allele |
dc.subject.otherIndex |
amino acid metabolism |
dc.subject.otherIndex |
article |
dc.subject.otherIndex |
blood sampling |
dc.subject.otherIndex |
body mass |
dc.subject.otherIndex |
controlled study |
dc.subject.otherIndex |
DNA polymorphism |
dc.subject.otherIndex |
female |
dc.subject.otherIndex |
gender |
dc.subject.otherIndex |
gene frequency |
dc.subject.otherIndex |
gene mutation |
dc.subject.otherIndex |
genotype |
dc.subject.otherIndex |
heterozygote |
dc.subject.otherIndex |
homozygosity |
dc.subject.otherIndex |
human |
dc.subject.otherIndex |
human experiment |
dc.subject.otherIndex |
male |
dc.subject.otherIndex |
normal human |
dc.subject.otherIndex |
priority journal |
dc.subject.otherIndex |
Adolescent |
dc.subject.otherIndex |
Adult |
dc.subject.otherIndex |
Base Sequence |
dc.subject.otherIndex |
DNA Primers |
dc.subject.otherIndex |
Female |
dc.subject.otherIndex |
Homocysteine |
dc.subject.otherIndex |
Humans |
dc.subject.otherIndex |
Lebanon |
dc.subject.otherIndex |
Male |
dc.subject.otherIndex |
Methylenetetrahydrofolate Reductase (NADPH2) |
dc.subject.otherIndex |
Middle Aged |
dc.subject.otherIndex |
Polymerase Chain Reaction |
dc.subject.otherIndex |
Young Adult |
dc.subject.otherKeywordPlus |
CORONARY-ARTERY-DISEASE |
dc.subject.otherKeywordPlus |
NEURAL-TUBE DEFECTS |
dc.subject.otherKeywordPlus |
TURKISH POPULATION-SAMPLE |
dc.subject.otherKeywordPlus |
SERUM TOTAL HOMOCYSTEINE |
dc.subject.otherKeywordPlus |
PLASMA HOMOCYSTEINE |
dc.subject.otherKeywordPlus |
MTHFR GENE |
dc.subject.otherKeywordPlus |
COMMON MUTATION |
dc.subject.otherKeywordPlus |
HIGH PREVALENCE |
dc.subject.otherKeywordPlus |
RISK-FACTOR |
dc.subject.otherKeywordPlus |
CARDIOVASCULAR-DISEASE |
dc.subject.otherWOS |
Genetics and Heredity |